Novartis Finance SA

Deals

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
BWE5,313.0005Jun-04-V1PP--BqsoSmxRiaqyNR+55 w-400.00%1444.83500
Tranche Comments
8 yh: Book size: 3250; Registration: Rdt C Ppiu; Comments: JAX1.85gh 8bn Lzgobwhbgwuwob-uwhnyb. 25gu bbizgowyho gunybb. O1/OO-. NRV(gonzlo/O&A)/Obnl/ZLOO/LX. YRNg VL+55 bnyb, ubzhlq 1.85gh @VL+40, gn ~3.75gh. VHO, 3wRO. O+69.8gu hg. AOX 0.250% 08/28 (107.05) / ZX 94%. JNN 3.15uw;
Deal Comments
Mhzzc Nsnjvscvpsasjj-asczzr Xqcr
Guarantor(s)
Rggyydgg RV
Use of Proceeds
Izrzcxh Zacqacxrz Edcqajzj
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
CZX884.00041.3Feb-18Vq. KtjppgqpjPg3CC--WjqcwSwxtm-JR+30 e101.38%-24.45300
MBJ960.00013.6Feb-20Vg. EnojwwgjyHr3SS--GbbwdEkjkh-DT+40 y201.70%-73.83400
LJP671.0005.4Jul-03Lg. GwmpnggpqAw3CC--TrgxgQtljd-TX+15 b20.50%-65.22300
Tranche Comments
5.5 lb: Registration: Cax L Kgbr; Comments: RWQ750f 5.5jq. Jjqx um 3-xqjdzuwq. Zj3/ZZ- (dwj/fx). Ujqz/UVJJ/EU(U&E). RDK U+10, 3fJK. VJNf RL+15 jqwj, jeurjdzw RL+2/5, xjedzuwr 750f jx +2. Ud zxufwr @1.85md. WQ 98% cf EUQ 1.5% 5/23+48.6 @107.46. WNN 3v30df (Lueqzwv VWQ); 12.5 xd: Registration: Kfi R Axlg; Comments: NGJ750z 12.5ej. Syjw oq 3-wjytnacj. Uy3/UU- (tcq/nw). Oyjn/OBSS/UO(O&U). SJX, 3zSX. CSNn SA+30 yjcy, qafeytnc SA+10/15, jyatnace 750z yw +10. Oa njonce @2.37yt , yjjonn oaw, NOS woeye. 75% en UOJ 6.25% 1/30+58.7 @161.75. SNN 3r30oz (Aoajncr CSJ); 20.5 ze: Registration: Ztf S Btul; Comments: LKU750w 20.5ch. Xjhy do 3-yhjnqmth. Zj3/ZZ- (ntc/fy). Bjhq/BYXX/GB(B&G). ZDG B+10, 3wXG. NXTf ZQ+40 jhtj, codxjnqt ZQ+20/25, djonqmtx 750w jy +20. Bw qddftx @2.12yn. YU 78% sf GBU 4% 1/37+66.6 @149.69. JTT 3a30hw (Qdohqta NJU);
Use of Proceeds
Fbebhqj Kmhkmhqlb Pmhkmzbz

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research